Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-011410

President and CEO acquired 13,066 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sibold William John President and CEO 2025-03-05 Grant or award +13,066 117,369 D
Derivatives
Sibold William John President and CEO 2025-03-05 Grant or award · Stock Option (Right to Buy) +22,009 22,009 D
Loading xslF345X05/wk-form4_1741387671.xml…